10 insiders reported 215 Form 4 transactions for LIGAND PHARMACEUTICALS INC (LGND) over the past 18 months (most recent 2026-07-06). Recent activity: Davis Todd C (Chief Executive Officer) Buy 132 shares, Espinoza Octavio (Chief Financial Officer) Buy 17 shares, Reardon Andrew (CLO & Secretary) Buy 132 shares, Reardon Andrew (CLO & Secretary) Buy 5,000 shares, Reardon Andrew (CLO & Secretary) Sell 396 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Davis Todd C | Chief Executive Officer | Buy | 132 | $21,214 |
| 2026-07-06 | Espinoza Octavio | Chief Financial Officer | Buy | 17 | $2,732 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Buy | 132 | $21,214 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 396 | $122,359 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 104 | $32,261 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 1,119 | $348,815 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 1,081 | $337,573 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 700 | $219,420 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 100 | $31,458 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 900 | $284,200 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 600 | $190,291 |
| 2026-06-18 | Sabba Stephen L | Director | Buy | 2,145 | $141,849 |
| 2026-06-18 | Sabba Stephen L | Director | Sell | 2,145 | $544,830 |
| 2026-06-12 | Aryeh Jason | Director | Buy | 836 | $0 |
| 2026-06-12 | LAMATTINA JOHN L | Director | Sell | 257 | $63,536 |
| 2026-06-12 | Aryeh Jason | Director | Sell | 500 | $125,000 |
| 2026-06-12 | LAMATTINA JOHN L | Director | Sell | 232 | $57,562 |
| 2026-06-12 | Aryeh Jason | Director | Sell | 4,500 | $1.1M |
| 2026-06-12 | LAMATTINA JOHN L | Director | Sell | 697 | $173,924 |
| 2026-06-12 | LAMATTINA JOHN L | Director | Sell | 3,405 | $856,752 |
| 2026-06-09 | Haas Jason | Director | Buy | 836 | $0 |
| 2026-06-09 | Sabba Stephen L | Director | Buy | 836 | $0 |
| 2026-06-09 | Gray Nancy Ryan | Director | Buy | 836 | $0 |
| 2026-06-09 | KOZARICH JOHN W | Director | Buy | 836 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06